Our results suggest that LMK235 may be a useful pharmacological agent for the treatment of hypertension through relaxation of vascular contraction or attenuation of vascular hyperplasia although LMK235 does not act as a class IIa selective HDAC inhibitor. The gene discussed is HDAC9; the disease is hypertensive disorder.